Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intensity-modulated radiotherapy (IMRT) in the treatment of squamous cell anal canal cancer: acute and early-late toxicity, outcome, and efficacy.
Dell'Acqua V, Surgo A, Arculeo S, Zerella MA, Bagnardi V, Frassoni S, Zampino MG, Ravenda PS, Rotundo MS, Kraja F, Kobiela J, Spychalski P, Fodor C, Gerardi MA, Cattani F, Bazani A, Petz W, Glynne-Jones R, Orecchia R, Leonardi MC, Jereczek-Fossa BA. Dell'Acqua V, et al. Among authors: zampino mg. Int J Colorectal Dis. 2020 Apr;35(4):685-694. doi: 10.1007/s00384-020-03517-x. Epub 2020 Feb 8. Int J Colorectal Dis. 2020. PMID: 32036405
Cisplatin plus capecitabine concomitant with intensity-modulated radiation therapy in non-metastatic anal squamous cell carcinoma: the experience of a single research cancer center.
Rotundo MS, Zampino MG, Ravenda PS, Bagnardi V, Peveri G, Dell'Acqua V, Surgo A, Trovato C, Bottiglieri L, Bertani E, Petz WL, Fumagalli Romario U, Fazio N. Rotundo MS, et al. Among authors: zampino mg. Ther Adv Med Oncol. 2020 Jul 15;12:1758835920940945. doi: 10.1177/1758835920940945. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32728394 Free PMC article.
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial.
Rosati G, Lonardi S, Galli F, Di Bartolomeo M, Ronzoni M, Zampino MG, Banzi M, Zaniboni A, Pasini F, Bozzarelli S, Garattini SK, Ferrari D, Montesarchio V, Mambrini A, Ciuffreda L, Galli F, Pusceddu V, Carlomagno C, Bidoli P, Amoroso D, Bochicchio AM, Frassineti L, Corsi D, Bilancia D, Pastorino A, De Stefano A, Labianca R; TOSCA (Three or Six Colon Adjuvant) investigators. Rosati G, et al. Among authors: zampino mg. Eur J Cancer. 2021 May;148:190-201. doi: 10.1016/j.ejca.2021.01.051. Epub 2021 Mar 18. Eur J Cancer. 2021. PMID: 33744715
Intensity-modulated radiotherapy and cisplatin-based chemotherapy for anal cancer: long-term outcomes at a single institution.
Gerardi MA, Zerella MA, Bergamaschi L, Ferrari A, Arculeo S, Bagnardi V, Frassoni S, Petz W, Fodor C, Emiro F, Cattani F, Leonardi MC, Zampino MG, Jereczek-Fossa BA. Gerardi MA, et al. Among authors: zampino mg. Int J Colorectal Dis. 2023 May 10;38(1):123. doi: 10.1007/s00384-023-04400-1. Int J Colorectal Dis. 2023. PMID: 37162567
Circulating tumor DNA in patients with locally advanced rectal cancer treated with multimodal treatment.
Gervaso L, Ciardiello D, Gregato G, Guidi L, Valenza C, Ascione L, Boldrini L, Frassoni S, Cella CA, Spada F, Funicelli L, De Roberto G, Petz W, Borin S, Gerardi MA, Bottiglieri L, Tamayo D, Bertani E, Fumagalli Romario U, Bagnardi V, Curigliano G, Bertolini F, Fazio N, Zampino MG. Gervaso L, et al. Among authors: zampino mg. Ther Adv Med Oncol. 2024 Jun 13;16:17588359241249602. doi: 10.1177/17588359241249602. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38882445 Free PMC article.
Rectal cancer.
Zampino MG, Labianca R, Beretta G, Gatta G, Lorrizo K, Braud Fd Fd, Wils J. Zampino MG, et al. Crit Rev Oncol Hematol. 2004 Aug;51(2):121-43. doi: 10.1016/j.critrevonc.2004.03.004. Crit Rev Oncol Hematol. 2004. PMID: 15276176 Review.
117 results